Skip to main content
. 2022 Mar 29;6(7):2045–2054. doi: 10.1182/bloodadvances.2020004079

Table 2.

Infections organized by type and subtype and organ system

Severity of infection
Number of infection events (n = 47) Number of patients (n = 55)
Any severity* High severity Any severity* High severity
Any infection, n (%) 47 (100) 4 (9) 29 (53) 3 (6)
Bacterial infections, n (%) 19 (40) 3 (6) 15 (27) 3 (6)
Bacterial site, n (%) 14 (30) 2 12 (22) 2 (4)
Gram-positive bacteremia, n (%) 2 (4) 0 (0) 2 (4) 0 (0)
Gram-negative bacteremia, n (%) 3 (6) 1 (2) 3 (6) 2 (4)
Viral infections, n (%) 25 (53) 0 (0) 18 (33) 2 (4)
Respiratory virus, n (%) 25 (53) 0 (0) 18 (33) 2 (4)
Other, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Fungal infection, n (%) 3 (6) 1 (2) 3 (6) 1 (2)
Mold fungal, n (%) 2 (4) 1 (2) 2 (4) 1 (2)
Nonmold fungal, n (%) 1 (2) 0 (0) 1 (2) 0 (0)
Organ system
 Lower respiratory, n (%) 16 (34) 0 (0) 14 (30) 2 (4)
 Upper respiratory, n (%) 16 (34) 0 (0) 14 (30) 2 (4)
 Bloodstream, n (%) 1 (2) 1 (2) 1 (2) 1 (2)
 GI, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
 CNS, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
 Other,§ n (%) 14 (30) 3 (6) 9 (16) 2 (4)

CNS, central nervous system; GI, gastrointestinal.

*

Any severity: infections that are mild, moderate, severe, life-threatening, or fatal.

High severity: infections that are severe, life-threatening, or fatal.

Site-specific bacterial infections were defined as evidence of bacterial infection by culture of a normally sterile site or by culture and evidence of tissue invasion of a nonsterile site.

§

Other includes skin and urinary tract, among other infections.